Skip to Main Content

The (POGO) Blog

March 28, 2017

By Ari Goldberg

POGO's 2017 Baker’s Dozen Wishlist for Congress



Aerial U.S. Capitol Building The Project On Government Oversight (POGO) has unveiled its biennial list of 13 policy areas ripe for Congressional action. It includes recommendations for legislative fixes to make the federal government more transparent, accountable, and ethical.

Continue Reading POGO's 2017 Baker’s Dozen Wishlist for Congress

Topics: Government Accountability, Open Government, Whistleblower Protections, Energy and Natural Resources, National Security, Public Health and Science, Contract Oversight

March 3, 2017

By David S. Hilzenrath

Trump’s Dangerous Prescription for the FDA



President Trump addressing a joint session of Congress, with VP Mike Pence and Rep. Paul Ryan seated behind him, clapping. President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.

Continue Reading Trump’s Dangerous Prescription for the FDA

Topics: Government Accountability, Open Government, Public Health and Science

August 12, 2016

By David S. Hilzenrath

UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO



Picture of a drop of blood on thumb. Alere Inc., maker of faulty INRatio blood testing devices, said it has received a Justice Department subpoena for records related to the devices’ accuracy and “interactions with the FDA.”

Continue Reading UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO

Topics: Government Accountability, Public Health and Science

July 13, 2016

By David S. Hilzenrath

FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss



Picture of a drop of blood on thumb. The FDA said faulty INRatio blood testing devices had “minimal” impact on a clinical trial of blood thinner Xarelto that FDA head Robert Califf co-chaired.

Continue Reading FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss

Topics: Government Accountability, Public Health and Science

July 13, 2016

By David S. Hilzenrath

Faulty Blood Testing Devices to Be Withdrawn from Market



Photograph of a finger prick with blood drop Alere, maker of INRatio blood testing devices whose potentially fatal flaws POGO spotlighted, said it is taking the machines off the market.

Continue Reading Faulty Blood Testing Devices to Be Withdrawn from Market

Topics: Government Accountability, Public Health and Science

Items 1 - 5 of 27  123456Next

Browse POGOBlog by Topic

POGO on Facebook

POGOBlog Contributors

See All Blog Contributors